1. HBW Insight

RB To Split OTC And Infant Nutrition As CEO Hits Reset Button

 
• By Tom Gallen

Reckitt Benckiser's new CEO Laxman Narasimhan has unveiled a turnaround plan which will see the company's OTC drugs and dietary supplements housed in a separate business to its infant nutrition products. RB is investing £2bn to get back on track after a couple of difficult years.

Hand man doing finances and calculate on desk about cost at home office.
• Source: Shutterstock

Reckitt Benckiser Group PLC’s Health business became “large, unwieldy and unfocused” under previous management, stated the firm’s new CEO Laxman Narasimhan.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Strategy

More from Business